And despite the sales slump in the U.S. this past quarter, Pfizer’s Prevnar dynasty still leads in pediatric pneumococcal vaccination worldwide and among conjugated pneumococcal vaccines for adults in ...
8don MSN
High demand for private COVID-19 shots sparks supply problems, waitlists for Alberta pharmacies
Some Alberta pharmacists say they've started waitlists for private COVID-19 vaccines because they can't get their hands on ...
Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...
Pfizer raised its full-year profit forecast for the second consecutive quarter and reported a higher-than-expected ...
LOS ANGELES -- The COVID-19 vaccines made by Pfizer and Moderna both require two doses to be administered, several weeks apart, for them to be fully effective. But there has been some scientific ...
Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...
Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...
Most people won't experience allergic reactions to the vaccine, experts insist. The Food and Drug Administration late Friday authorized Pfizer's COVID-19 vaccine for people ages 16 and up, but warned ...
At a price of up to $10 billion, Pfizer has claimed victory in its bidding war against Novo Nordisk to acquire Metsera. It's ...
(CNN) — In response to a call from President Donald Trump to make the positive impact of Covid-19 vaccines public, drug giant Pfizer posted a collection of more than 200 news releases and statements ...
Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday as both companies submitted sweetened bids, with Metsera saying Novo's $10 billion offer is superior.Pfizer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results